[RGLS] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
19-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -118.74%
YoY- -444.02%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 4,759 3,238 3,238 2,809 3,309 3,344 3,363 26.07%
PBT -7,338 -7,239 -6,858 -5,691 -2,621 -2,246 -1,940 142.96%
Tax 10 -10 18 -6 -22 1 75 -73.93%
NP -7,348 -7,229 -6,876 -5,685 -2,599 -2,247 -2,015 137.10%
Tax Rate - - - - - - - -
Total Cost 12,107 10,467 10,114 8,494 5,908 5,591 5,378 71.85%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -154.40 -223.26 -212.35 -202.39 -78.54 -67.19 -59.92 88.06%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -24.50 -24.18 -23.03 -1,918.02 -1,293.03 -1,568.04 -2,704.70 -95.66%
EPS Diluted -24.50 -24.18 -23.00 -1,918.02 -1,293.03 -1,568.04 -2,704.70 -95.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.